Memorize Last-Minute For Exam Flashcards
(45 cards)
Epidemiology of panic disorder
- prevalence: 1.5-5% (one of the top five most common reasons to see a family doctor); M:F = 1:2-3
- onset: average late 20’s, familial pattern
Medical Workup of Anxiety
- routine screening: physical examination, CBC, thyroid function test, electrolytes, urinalysis, urine drug screening
- additional screening: neurological consultation, chest x-ray, ECG, CT
Px of panic disorder
- 6-10 yr post-treatment: 30% well, 40-50% improved, 20-30% no change or worse
- clinical course: chronic, but episodic with psychosocial stressors
Definition of agoraphobia
anxiety about being in places or situations from which escape might be difficult (or embarrassing) or where help may not be available in the event of having an unexpected panic attack
fears commonly involve situations such as being out alone, being in a crowd, standing in a line, or travelling on a bus
• situations are avoided, endured with anxiety or panic, or require companion
• treatment: as per panic disorder
Time frame for GAD
occurring more days than not for at least 6 mo
In GAD, the anxiety and worry are associated with ≥3 of the following 6 symptoms (with at least some symptoms present for more days than not for the past 6 mo)
Note: Only one item is required in children
restlessness or feeling keyed up or on edge
being easily fatigued
difficulty concentrating or mind going blank
irritability
muscle tension
sleep disturbance (difficulty falling or staying asleep, or restless unsatisfying sleep)
GAD epidemiology and Px
• 1-yr prevalence: 3-8%; M:F = 1:2
if considering only those receiving inpatient treatment, ratio is 1:1
• most commonly presents in early adulthood
Px:
• chronically anxious adults become less so with age
• depends on pre-morbid personality functioning, stability of relationships, work, and severity of environmental stress
• difficult to treat
Specific phobia lifetime prevalence
lifetime prevalence 12-16%; M:F ratio variable
Social phobia lifetime prevalence
• lifetime prevalence may be as high as 13-16%; F>M
OCD lifetime prevalence
lifetime prevalence rates 2-3%; M=F
Acute stress d/o
Acute Stress Disorder
May be a precursor to PTSD
Criteria:
• Exposure to traumatic event
• Dissociative symptoms
• Event is persistently re-experienced
• Avoidance of stimuli
• Symptoms of anxiety or increased arousal
• Causes clinically significant distress or impairment in social, occupational or other important areas of functioning
• Symptoms last 2 d to 4 wk and occur within 4 wk of event
Criteria for Post-Traumatic Stress Disorder
TRAUMA Traumatic event Re-experience the event Avoidance of stimuli associated with the trauma Unable to function More than a Month Arousal increased
PTSD epidemiology
• prevalence in general population: 7%
• men’s trauma is most commonly combat experience/physical assault; women’s trauma is usually
physical or sexual assault
Medical Workup of Mood Disorder
• routine screening: physical examination, CBC, thyroid function test, electrolytes, extended
electrolytes, urinalysis, drug screen
• additional screening: neurological consultation, chest x-ray, ECG, CT
Time frame for MDE
≥5 of the following symptoms have been present during the same 2-wk period and represent a change from previous functioning; at least one of the symptoms is either 1) depressed mood or 2) loss of interest or pleasure (anhedonia)
Criteria for Mania
. a distinct period of abnormally and persistently elevated, expansive, or irritable mood, lasting ≥1 wk (or any duration if hospitalization is necessary)
GST PAID - (≥3) (4 if the mood is only irritable) Grandiosity Sleep (decreased need) Talkative Pleasurable activities, Painful consequences Activity Ideas (flight of) Distractible
Mixed Episode
- criterion met for both manic episode and MDE nearly every day for 1 wk
- criteria D and E of manic episodes are met
- Note: in DSM-5, mixed episode is no longer a separate mood diagnosis; instead, depressed episodes and manic episodes can have a “with mixed features” specifier
Hypomanic episode
- criterion A of a manic episode is met, but duration is ≥4 d
- criteria B and E of manic episodes are met
- episode associated with an uncharacteristic decline in functioning that is observable by others
- change in function is not severe enough to cause marked impairment in social or occupational functioning or to necessitate hospitalization
- absence of psychotic features
MDD risk factors
- sex: female > male
- age: onset between 25-50 yr of age
- family history: depression, alcohol abuse, sociopathy
- childhood experiences: loss of parent before age 11, negative home environment (abuse, neglect)
- personality: insecure, dependent, obsessional
- recent stressors: illness, financial, legal
- postpartum <6 mo
- lack of intimate, confiding relationships or social isolation
MDD epidemiology
Epidemiology
• prevalence: 12.2%
lifetime prevalence: male 2.9%, female 5%
annual prevalence: peak prevalence age 15-25 yr (M:F = 1:2)
• genetic: 65-75% MZ twins; 14-19% DZ twins
Neurotransmitters in MDD
neurotransmitter dysfunction: decreased activity of 5HT, NE and DA at the level of the synapse; changes in GABA and glutamate
MDD Px
Prognosis
• one year after diagnosis of a MDE without treatment: 40% of individuals still have symptoms that are sufficiently severe to meet criteria for a full MDE, 20% continue to have some symptoms
that no longer meet criteria for a MDE, 40% have no mood disorder
Dysthymia (PDD) time lines
Depressed mood for most of the day, for more days than not, for ≥2 yr
Note: In children and adolescents, mood can be irritable and duration must be at least 1 yr
During the 2-yr period (1 yr for children or adolescents) of the disturbance, the person has never been without the symptoms in criteria A and B for more than 2 mo at a time
Dysthymia Epidemiology & Tx
Epidemiology
• point prevalence: 3%; life prevalence: 6%; M:F = 1:2-3
Treatment • psychological principal treatment for dysthymia individual, group, and family therapy • biological antidepressant therapy (SSRIs/SNRIs) as an outpatient